Potentiation of hypothalamic corticotropin releasing activity by vasopressin: studies in the Brattleboro rat.
D000324:Adrenocorticotropic Hormone / Q000378:metabolism; D000818:Animals; D001127:Arginine Vasopressin / Q000276:immunology / Q000494:pharmacology; D003346:Corticotropin-Releasing Hormone / Q000502:physiology*; D003919:Diabetes Insipidus / Q000503:physiopathology*; D004357:Drug Synergism; D007031:Hypothalamus / Q000187:drug effects / Q000503:physiopathology*; D007106:Immune Sera / Q000494:pharmacology; D066298:In Vitro Techniques; D008297:Male; D010903:Pituitary Gland, Anterior / Q000503:physiopathology; D051381:Rats; D011910:Rats, Brattleboro / Q000502:physiology*; D011922:Rats, Mutant Strains / Q000502:physiology*; D014667:Vasopressins / Q000502:physiology*
D007106:Immune Sera; D014667:Vasopressins; D001127:Arginine Vasopressin; D000324:Adrenocorticotropic Hormone; D003346:Corticotropin-Releasing Hormone